Company news

In 2021, the revenue from the sale of isotope products from Russia's Electrochemical Plant (part of Rosatom's Fuel Company TVEL) increased by 8% year-on-year, to more than RUB1.6 billion ($20m) for the first time.

Taking place as part of World Expo 2020 in Dubai (UAE), ROSATOM’s thematic weeklong event “Breakthrough Technologies for a Sustainable Future” came to a close on January 24. The event – unprecedented in terms of scale – saw ROSATOM representatives taking part in 18 sessions dedicated to the role of advanced technologies in achieving a sustainable future and solving the most pressing challenges of our time.

Rusatom Healthcare JSC is part of the Russian pavilion at the Dubai EXPO where they organised a discussion on “non energy applications of nuclear technology for addressing global challenges”.

8 November 2021, Glasgow, UK – “Clean Nuclear Energy Day” took place on November 8 as part of the twenty-sixth session of the Conference of the Parties (COP26), held in the United Nations Framework Convention on Climate Change (UNFCCC). The special “Clean Nuclear Energy Day” programme was made possible with ROSATOM’s support.

Isotope JSC participated in 34th Annual Congress of the European Association of Nuclear Medicine on October 20-23, 2021. Due to the pandemic, the congress was held virtually for the second year in a row.

The ROSATOM’s first Sustainable Development Report for 2020 was first posted on the website of the UN Global Compact Network October 1, 2021. The report is qualified rated at level “Active”.

ROSATOM took part in the XXXV Brazilian Congress of Nuclear Medicine (CBMN) as a Gold Sponsor. The event took place in Brazil on September, 3-6. Due to the coronavirus pandemic, the event was held virtually.

On September, 2-4 representatives of Isotope JSC took part in the second Russian-Italian scientific conference "Challenges of oncology in the era of COVID-19 ", held in a hybrid format in Taranto (Italy).

ROSATOM took part in the international online conference Nuclear Trade and Technology Exchange (NT2E), organized by the Brazilian Association for the Development of Nuclear Activities (ABDAN) on July 27-29, 2021.

Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute (IPEN; linked to the National Nuclear Energy Commission or CNEN) to supply lutetium-177 and actinium-225, the most promising medical isotopes in Radiopharma.